These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

588 related articles for article (PubMed ID: 9416447)

  • 1. From laboratory to clinic: a large scale study of distortion product otoacoustic emissions in ears with normal hearing and ears with hearing loss.
    Gorga MP; Neely ST; Ohlrich B; Hoover B; Redner J; Peters J
    Ear Hear; 1997 Dec; 18(6):440-55. PubMed ID: 9416447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distortion product otoacoustic emission test performance for a priori criteria and for multifrequency audiometric standards.
    Gorga MP; Neely ST; Dorn PA
    Ear Hear; 1999 Aug; 20(4):345-62. PubMed ID: 10466570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Otoacoustic emissions from normal-hearing and hearing-impaired subjects: distortion product responses.
    Gorga MP; Neely ST; Bergman B; Beauchaine KL; Kaminski JR; Peters J; Jesteadt W
    J Acoust Soc Am; 1993 Apr; 93(4 Pt 1):2050-60. PubMed ID: 8473617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dependence of distortion-product otoacoustic emissions on primary levels in normal and impaired ears. I. Effects of decreasing L2 below L1.
    Whitehead ML; McCoy MJ; Lonsbury-Martin BL; Martin GK
    J Acoust Soc Am; 1995 Apr; 97(4):2346-58. PubMed ID: 7714254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting audiometric status from distortion product otoacoustic emissions using multivariate analyses.
    Dorn PA; Piskorski P; Gorga MP; Neely ST; Keefe DH
    Ear Hear; 1999 Apr; 20(2):149-63. PubMed ID: 10229516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distortion product otoacoustic emission test performance when both 2f1-f2 and 2f2-f1 are used to predict auditory status.
    Gorga MP; Nelson K; Davis T; Dorn PA; Neely ST
    J Acoust Soc Am; 2000 Apr; 107(4):2128-35. PubMed ID: 10790038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cochlear Mechanisms and Otoacoustic Emission Test Performance.
    Go NA; Stamper GC; Johnson TA
    Ear Hear; 2019; 40(2):401-417. PubMed ID: 29952805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of aging on distortion-product otoacoustic emissions in adults with normal hearing.
    Uchida Y; Ando F; Shimokata H; Sugiura S; Ueda H; Nakashima T
    Ear Hear; 2008 Apr; 29(2):176-84. PubMed ID: 18595184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical test performance of distortion-product otoacoustic emissions using new stimulus conditions.
    Johnson TA; Neely ST; Kopun JG; Dierking DM; Tan H; Gorga MP
    Ear Hear; 2010 Feb; 31(1):74-83. PubMed ID: 19701088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distortion product otoacoustic emission response characteristics in older adults.
    Torre P; Cruickshanks KJ; Nondahl DM; Wiley TL
    Ear Hear; 2003 Feb; 24(1):20-9. PubMed ID: 12598810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of inner ear hearing loss on delayed otoacoustic emissions (TEOAE) and distortion products (DPOAE)].
    Hoth S
    Laryngorhinootologie; 1996 Dec; 75(12):709-18. PubMed ID: 9081275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.
    Reavis KM; Phillips DS; Fausti SA; Gordon JS; Helt WJ; Wilmington D; Bratt GW; Konrad-Martin D
    Ear Hear; 2008 Dec; 29(6):875-93. PubMed ID: 18753950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distortion-product otoacoustic emissions in middle-aged subjects with normal versus potentially presbyacusic high-frequency hearing loss.
    Nieschalk M; Hustert B; Stoll W
    Audiology; 1998; 37(2):83-99. PubMed ID: 9547922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient evoked otoacoustic emissions in patients with normal hearing and in patients with hearing loss.
    Hussain DM; Gorga MP; Neely ST; Keefe DH; Peters J
    Ear Hear; 1998 Dec; 19(6):434-49. PubMed ID: 9867292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further efforts to predict pure-tone thresholds from distortion product otoacoustic emission input/output functions.
    Gorga MP; Neely ST; Dorn PA; Hoover BM
    J Acoust Soc Am; 2003 Jun; 113(6):3275-84. PubMed ID: 12822800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hearing threshold estimation using concurrent measurement of distortion product otoacoustic emissions and auditory steady-state responses.
    Rosner T; Kandzia F; Oswald JA; Janssen T
    J Acoust Soc Am; 2011 Feb; 129(2):840-51. PubMed ID: 21361442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Audiometric predictions using stimulus-frequency otoacoustic emissions and middle ear measurements.
    Ellison JC; Keefe DH
    Ear Hear; 2005 Oct; 26(5):487-503. PubMed ID: 16230898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distortion product otoacoustic emissions in normal and hearing-impaired ears.
    Probst R; Hauser R
    Am J Otolaryngol; 1990; 11(4):236-43. PubMed ID: 2240411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cochlear generation of intermodulation distortion revealed by DPOAE frequency functions in normal and impaired ears.
    Stover LJ; Neely ST; Gorga MP
    J Acoust Soc Am; 1999 Nov; 106(5):2669-78. PubMed ID: 10573884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Distortion product otoacoustic emissions for the assessment of auditory sensitivity].
    Chida E
    Nihon Jibiinkoka Gakkai Kaiho; 1998 Nov; 101(11):1335-47. PubMed ID: 9867000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.